why choose us

Clinical Trials Search

Showing 1,810 of 130,066 result(s)
PRF Membrane and Recovery After Periapical Surgery: A 3D Imaging Study

Status: COMPLETED

Condition: Periapical Diseases

Interventions: The Platelet-Rich Fibrin (PRF) membrane is a biocompatible material derived from the participant's own blood and prepared through centrifugation.

Date: 2024-12-06

Therapeutic Effect of Manuka Honey Oral Rinse on Fibroblast Growth Factor-21 in Periodontitis Patients Undergoing Hemodialysis

Status: COMPLETED

Condition: Periodontitis

Interventions:

Name: Manuka Honey Oral Rinse

Description:

Dosage: Patients will use 20 ml of Manuka honey diluted in 100 ml of purified water.

A

Date: 2024-12-06

Pharmacokinetics and Pharmacodynamics of Two Prolonged-release Formulations of Vamifeport in Healthy Adults

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Vamifeport IRF will be administered orally as per the dosing levels and formulations for respective treatment periods.

Date: 2024-12-06

A Study to Characterize Single and Repeat Dose Pharmacokinetics of Tebipenem-Pivoxil-Hydrobromide (TBP-PI-HBr) and Its Major Metabolite (SPR1349) in Healthy Participants

Status: COMPLETED

Condition: Healthy Participants

Interventions: TBP-PI-HBr film-coated immediate-release tablets

Date: 2024-12-06

The Effect of Mandala on Anxiety, Physiological Parameters and Patient Satisfaction in Women With Breast Cancer

Status: COMPLETED

Condition: Breast Cancer

Interventions: The patient will undergo mandala painting during 1 session of chemotherapy.

Date: 2024-12-06

A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.

Status: COMPLETED

Condition: Liver Fibrosis

Interventions: Doses of AZD2389 or placebo will be administered orally.

Date: 2024-12-06

Transcranial Photobiomodulation With Patients With Parkinson's Disease

Status: COMPLETED

Condition: Parkinson Disease

Interventions: Single-session transcranial laser stimulation was administered with a continuous-wave, 1,064-nm laser (Model CG-5000 Laser, Cell Gen Therapeutics LLC,

Date: 2024-12-05

Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

Status: COMPLETED

Condition: Type 2 Diabetes

Interventions: Acetaminophen

Date: 2024-12-05

A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.

Status: COMPLETED

Condition: Healthy Participants

Interventions: Oral formulation

Date: 2024-12-05

Influence of HRS9531 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin in Healthy Subjects

Status: COMPLETED

Condition: Type 2 Diabetes

Interventions: Acetaminophen

Date: 2024-12-05